The effect of Fingolimod on patients with moderate to severe COVID‐19

The effect of Fingolimod on patients with moderate to severe COVID‐19

Abstract Hyper‐inflammation, cytokine storm, and recruitment of immune cells lead to uncontrollable endothelial cell damage in patients with coronavirus disease 2019 (COVID‐19). Sphingosine 1‐phosphate (S1P) signaling is needed for endothelial integrity and its decreased serum level is a predictor o...

Full description

Bibliographic Details
Main Authors: Soheil Teymouri, Siamak Pourbayram Kaleybar, Seyyed Sina Hejazian, Seyyedeh Mina Hejazian, Khalil Ansarin, Mohammadreza Ardalan, Sepideh Zununi Vahed
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Pharmacology Research & Perspectives
Subjects:
COVID‐19
cytokine storm
Fingolimod
sphingosine 1‐phosphate
Online Access:https://doi.org/10.1002/prp2.1039

Internet

https://doi.org/10.1002/prp2.1039

Similar Items